274 related articles for article (PubMed ID: 22732211)
1. Triacylglycerol-rich lipoproteins protect lipoprotein lipase from inactivation by ANGPTL3 and ANGPTL4.
Nilsson SK; Anderson F; Ericsson M; Larsson M; Makoveichuk E; Lookene A; Heeren J; Olivecrona G
Biochim Biophys Acta; 2012 Oct; 1821(10):1370-8. PubMed ID: 22732211
[TBL] [Abstract][Full Text] [Related]
2. Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1.
Lichtenstein L; Kersten S
Biochim Biophys Acta; 2010 Apr; 1801(4):415-20. PubMed ID: 20056168
[TBL] [Abstract][Full Text] [Related]
3. Regulation of triglyceride metabolism by Angiopoietin-like proteins.
Mattijssen F; Kersten S
Biochim Biophys Acta; 2012 May; 1821(5):782-9. PubMed ID: 22063269
[TBL] [Abstract][Full Text] [Related]
4. Physiological regulation of lipoprotein lipase.
Kersten S
Biochim Biophys Acta; 2014 Jul; 1841(7):919-33. PubMed ID: 24721265
[TBL] [Abstract][Full Text] [Related]
5. GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4.
Sonnenburg WK; Yu D; Lee EC; Xiong W; Gololobov G; Key B; Gay J; Wilganowski N; Hu Y; Zhao S; Schneider M; Ding ZM; Zambrowicz BP; Landes G; Powell DR; Desai U
J Lipid Res; 2009 Dec; 50(12):2421-9. PubMed ID: 19542565
[TBL] [Abstract][Full Text] [Related]
6. The Regulation of Triacylglycerol Metabolism and Lipoprotein Lipase Activity.
Wen Y; Chen YQ; Konrad RJ
Adv Biol (Weinh); 2022 Oct; 6(10):e2200093. PubMed ID: 35676229
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
Zsigmond E; Kobayashi K; Tzung KW; Li L; Fuke Y; Chan L
Hum Gene Ther; 1997 Nov; 8(16):1921-33. PubMed ID: 9382958
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix.
Saxena U; Klein MG; Vanni TM; Goldberg IJ
J Clin Invest; 1992 Feb; 89(2):373-80. PubMed ID: 1737833
[TBL] [Abstract][Full Text] [Related]
9. Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo.
Heeren J; Niemeier A; Merkel M; Beisiegel U
J Mol Med (Berl); 2002 Sep; 80(9):576-84. PubMed ID: 12226739
[TBL] [Abstract][Full Text] [Related]
10. Particle size determines effects of lipoprotein lipase on the catabolism of n-3 triglyceride-rich particles.
Xia L; Fan C; Dong H; Wang C; Lu Y; Deckelbaum RJ; Qi K
Clin Nutr; 2015 Aug; 34(4):767-74. PubMed ID: 25048714
[TBL] [Abstract][Full Text] [Related]
11. Regulation of lipoprotein lipase by Angptl4.
Dijk W; Kersten S
Trends Endocrinol Metab; 2014 Mar; 25(3):146-55. PubMed ID: 24397894
[TBL] [Abstract][Full Text] [Related]
12. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids.
Saxena U; Witte LD; Goldberg IJ
J Biol Chem; 1989 Mar; 264(8):4349-55. PubMed ID: 2925647
[TBL] [Abstract][Full Text] [Related]
13. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).
Lee EC; Desai U; Gololobov G; Hong S; Feng X; Yu XC; Gay J; Wilganowski N; Gao C; Du LL; Chen J; Hu Y; Zhao S; Kirkpatrick L; Schneider M; Zambrowicz BP; Landes G; Powell DR; Sonnenburg WK
J Biol Chem; 2009 May; 284(20):13735-13745. PubMed ID: 19318355
[TBL] [Abstract][Full Text] [Related]
14. Not all angiopoietin-like proteins (Angptls) are created equal: insights from molecular, genetic, and pharmacological studies on the mechanism of LPL inhibition by Angptl3 and Angptl4.
Li C
Curr Opin Lipidol; 2009 Aug; 20(4):357-9. PubMed ID: 19584596
[No Abstract] [Full Text] [Related]
15. Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.
Chi X; Shetty SK; Shows HW; Hjelmaas AJ; Malcolm EK; Davies BS
J Biol Chem; 2015 May; 290(19):11865-77. PubMed ID: 25809481
[TBL] [Abstract][Full Text] [Related]
16. Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake.
Lichtenstein L; Berbée JF; van Dijk SJ; van Dijk KW; Bensadoun A; Kema IP; Voshol PJ; Müller M; Rensen PC; Kersten S
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2420-7. PubMed ID: 17761937
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
[TBL] [Abstract][Full Text] [Related]
18. Preparation of chylomicrons and VLDL with monoacid-rich triacylglycerol and characterization of kinetic parameters in lipoprotein lipase-mediated hydrolysis in chickens.
Sato K; Takahashi T; Takahashi Y; Shiono H; Katoh N; Akiba Y
J Nutr; 1999 Jan; 129(1):126-31. PubMed ID: 9915888
[TBL] [Abstract][Full Text] [Related]
19. Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer.
Liu G; Excoffon KJ; Wilson JE; McManus BM; Miao L; Benoit P; Duverger N; Branellec D; Denefle P; Hayden MR; Lewis ME
Clin Invest Med; 1998; 21(4-5):172-85. PubMed ID: 9800066
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases.
Liu J; Afroza H; Rader DJ; Jin W
J Biol Chem; 2010 Sep; 285(36):27561-70. PubMed ID: 20581395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
